A genetically engineered herpes simplex virus, when combined with immunotherapy, reduces or eliminates tumors in one-third of clinical trial patients.
In a USC study, 30 days of app-guided meditation were linked to improvements in how quickly and accurately participants directed their focus.
The Chung Lab at USC Viterbi has engineered a therapeutically enhanced, naturally derived particle for powerful gene therapies.
A USC-led study finds that even storms below hurricane strength significantly increase infant deaths in low- and middle-income countries, and not just for the reasons experts expected.
In a proof-of-concept study, the test detected five key biomarkers of Alzheimer’s disease — more than current commercially available blood tests can measure.
The USC-led study’s findings uncover how the harmful effects of air pollution may contribute to long-term metabolic problems.
The donation from R. Rex Parris and his wife, Carrol, will enable collaboration among experts in engineering, gerontology and stem cell research to find treatments for age-related conditions.
The historic surgery — the result of years of research at Keck Medicine of USC and UCLA Health — opens the door for improved treatment of non-functioning bladders.
Experts in population health, engineering and medicine will study and address harms related to the manmade pollutants known as PFAS.
In USC-led research, the new drug candidate selectively attacked glioblastoma stem cells and passed early safety testing in a Phase 1 clinical trial.
